FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Guerbet Sodium Chloride Injection 0 Recall

Sodium Chloride Injection USP 0

GUERBET LLC · Princeton, NJ

Risk level
Class III
Reported by FDA
Oct 16, 2019
Recall ID
D-0138-2020
Check your lot numberHow we source this data

Summary

Guerbet recalled Sodium Chloride Injection 0 starting Sep 13, 2019. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0138-2020 on Oct 16, 2019. Reason: Labeling: Not Elsewhere Classified: RFID formatting error which reads product in Ultraject syringe as expired and will not allow injection of product by the Optivantage injector. Status: Terminated.

Why it was recalled

Labeling: Not Elsewhere Classified: RFID formatting error which reads product in Ultraject syringe as expired and will not allow injection of product by the Optivantage injector.

Product description

Sodium Chloride Injection USP 0.9%, packaged in 1 - 125 mL Ultraject Prefilled Syringe For Power Injection per carton, RFID Technology, Rx Only, Manufactured by: Liebel-Flarshelm Company, LLC., Raleigh, NC 27616; NDC 0019-1188-27.

Lot numbers, UPCs & expiration codes

Lots: L159A, Exp. 06/2021; L169A, Exp. 07/2021

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0138-2020
Classification
Class III
Status
Terminated
Recall initiated
Sep 13, 2019
FDA report date
Oct 16, 2019
Quantity
3140 syringes
Recall type
Voluntary: Firm initiated
Recalling firm
GUERBET LLC

Original FDA data

Every field from FDA enforcement report D-0138-2020, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Terminated
Country
United States
Event ID
83798
Address
821 Alexander Rd, Ste 204
Address (line 2)
120 W 7th St Suite
Code information
Lots: L159A, Exp. 06/2021; L169A, Exp. 07/2021
Postal code
08540-0000
Report date
Oct 16, 2019
Product type
Drugs
Recall number
D-0138-2020
Classification
Class III
Recalling firm
GUERBET LLC
Product quantity
3140 syringes
Termination date
Oct 25, 2021
Reason for recall
Labeling: Not Elsewhere Classified: RFID formatting error which reads product in Ultraject syringe as expired and will not allow injection of product by the Optivantage injector.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Sodium Chloride Injection USP 0.9%, packaged in 1 - 125 mL Ultraject Prefilled Syringe For Power Injection per carton, RFID Technology, Rx Only, Manufactured by: Liebel-Flarshelm Company, LLC., Raleigh, NC 27616; NDC 0019-1188-27.
Distribution pattern
Nationwide in the USA
Recall initiation date
Sep 13, 2019
Initial firm notification
Letter
Center classification date
Oct 9, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0138-2020, published Oct 16, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls